BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36709151)

  • 21. Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using
    Hao B; Zhao L; Luo NN; Ruan D; Pang YZ; Guo W; Fu H; Guo XY; Luo ZM; Wu J; Chen HJ; Wu H; Sun L
    BMC Cancer; 2018 Nov; 18(1):1192. PubMed ID: 30497426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the prognostic utility of bone marrow biopsy in diffuse large B-Cell lymphoma in the SEER-Medicare dataset.
    Luan D; Wu Y; Goldstein J; Rutherford S; Leonard JP; Martin P
    Leuk Lymphoma; 2021 Aug; 62(8):1850-1859. PubMed ID: 33627025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients.
    Chen S; Wang S; He K; Ma C; Fu H; Wang H
    Eur Radiol; 2018 Jul; 28(7):2942-2950. PubMed ID: 29383519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorodeoxyglucose-Positron Emission Tomography Predicts Bone Marrow Involvement in the Staging of Follicular Lymphoma.
    St-Pierre F; Broski SM; LaPlant BR; Maurer MJ; Ristow K; Thanarajasingam G; Macon WR; Habermann TM; Witzig TE
    Oncologist; 2020 Aug; 25(8):689-695. PubMed ID: 32319706
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of pelvic magnetic resonance imaging for the assessment of bone marrow involvement in diffuse large B-cell lymphoma.
    Ke Q; Liao CC; Tan XH; Guo BP; Cen H; Li LQ
    PLoS One; 2021; 16(5):e0252226. PubMed ID: 34043683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases.
    Büyükşimşek M; Kolsuz İ; Yetişir AE; Tohumcuoğlu M; Oğul A; Mirili C; Paydaş S; Güney İB
    Turk J Haematol; 2020 Nov; 37(4):220-225. PubMed ID: 32003552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?
    Kasalak Ö; Glaudemans AWJM; Overbosch J; Jutte PC; Kwee TC
    Skeletal Radiol; 2018 Mar; 47(3):363-367. PubMed ID: 29124298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma.
    Muslimani AA; Farag HL; Francis S; Spiro TP; Chaudhry AA; Chan VC; Taylor HC; Daw HA
    Am J Clin Oncol; 2008 Oct; 31(5):409-12. PubMed ID: 18838874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of bone marrow infiltration detected by PET-CT in newly diagnosed diffuse large B cell lymphoma.
    Liang JH; Sun J; Wang L; Fan L; Chen YY; Qu XY; Li TN; Li JY; Xu W
    Oncotarget; 2016 Apr; 7(14):19072-80. PubMed ID: 26919239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and Prognostic Value of Using 18F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell Lymphoma.
    Abe Y; Kitadate A; Usui Y; Narita K; Kobayashi H; Miura D; Takeuchi M; Oʼuchi E; Oʼuchi T; Matsue K
    Clin Nucl Med; 2019 May; 44(5):e336-e341. PubMed ID: 30889000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Ann Nucl Med; 2015 Feb; 29(2):132-7. PubMed ID: 25348549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of bone marrow biopsy and fluorodeoxyglucose-positron emission tomography for the assessment of bone marrow infiltration in children with Hodgkin's lymphoma.
    Arslantaş E; Ayçiçek A; Akıcı F; Özkara S; Yılmaz B; Özdemir N; Bayram C
    Nuklearmedizin; 2023 Feb; 62(1):20-26. PubMed ID: 36746148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of bone marrow involvement in extranodal NK/T cell lymphoma by FDG-PET/CT.
    Zhou Z; Chen C; Li X; Li Z; Zhang X; Chang Y; Lu L; Cui Y; Ma Y; Zhang M
    Ann Hematol; 2015 Jun; 94(6):963-7. PubMed ID: 25547320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing bone marrow involvement in diffuse large B-cell lymphoma with 18F-FDG PET/CT: A preliminary experience at Hospital Pulau Pinang.
    Siti Maisarah MN; Mahayuddin AM; Fadzilah H
    Med J Malaysia; 2021 Sep; 76(5):665-671. PubMed ID: 34508372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study.
    Ródenas-Quiñonero I; Chen-Liang T; Martín-Santos T; Salar A; Fernández-González M; Celades C; Navarro JT; Martínez-Garcia AB; Andreu R; Balaguer A; Martin García-Sancho A; Baile M; López-Jiménez J; Marquet-Palomanes J; Teruel AI; Terol MJ; Benet C; Frutos L; Navarro JL; Uña J; Suarez M; Cortes M; Contreras J; Ruiz C; Tamayo P; Mucientes J; Sopena-Novales P; Reguilón-Gallego L; Sánchez-Blanco JJ; Pérez-Ceballos E; Jerez A; Ortuño FJ
    Cancer Med; 2023 Mar; 12(6):6536-6546. PubMed ID: 36373169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D; Patti C; Lagalla R; Midiri M; Galia M
    J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic value of FDG-PET in the detection of bone marrow involvement in patients with diffuse large B-cell lymphoma].
    Zhang X; Fan W; Lin XP
    Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):832-5. PubMed ID: 19176040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials.
    Kaddu-Mulindwa D; Altmann B; Held G; Angel S; Stilgenbauer S; Thurner L; Bewarder M; Schwier M; Pfreundschuh M; Löffler M; Menhart K; Grosse J; Ziepert M; Herrmann K; Dührsen U; Hüttmann A; Barbato F; Poeschel V; Hellwig D
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3550-3559. PubMed ID: 33928400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.
    Kandeel AA; Hussein M; Zidan L; Younis J; Edesa W; Alsayed Y
    Nucl Med Commun; 2020 Mar; 41(3):269-279. PubMed ID: 31895758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.